EODData

FRA, GXE: Galapagos NV

03 Sep 2025
LAST:

26.54

CHANGE:
 0.02
OPEN:
26.40
HIGH:
26.54
ASK:
0.00
VOLUME:
1K
CHG(%):
0.08
PREV:
26.52
LOW:
26.40
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 2526.4026.5426.4026.541K
02 Sep 2526.6626.6626.5226.521K
01 Sep 2526.8226.8226.7026.701K
29 Aug 2527.5027.5026.6426.641K
28 Aug 2527.9027.9027.5427.541K
27 Aug 2527.1427.9027.1427.901K
26 Aug 2526.8427.1826.8427.181K
25 Aug 2527.1427.1426.9026.901K
22 Aug 2527.1027.1227.1027.121K
21 Aug 2526.9827.1226.9827.121K

COMPANY PROFILE

Name:Galapagos NV
About:Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Sector:Healthcare
Industry:Biotechnology
Address:Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Website:https://www.glpg.com
ISIN:BE0003818359
LEI:549300QKJ78IY0IOV655

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:26.79
MA10:27.02
MA20:27.19
MA50:26.52
MA100:25.20
MA200:24.64
STO9:1.45
STO14:1.39
RSI14:41.96
WPR14:-98.61
MTM14:-1.00
ROC14:-0.04
ATR:0.37
Week High:27.90
Week Low:26.40
Month High:28.75
Month Low:26.40
Year High:29.20
Year Low:20.09
Volatility:50.79